cbdMD Receives $1 Million Return of Capital Following Closing of Adara SPAC TransactionNewsfile Corp • 02/13/23
cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2023 ResultsNewsfile Corp • 02/06/23
cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent NewsNewsfile Corp • 01/26/23
cbdMD, Inc. to Host Conference Call to Discuss Fourth Quarter and Fiscal 2022 ResultsNewsfile Corp • 12/14/22
cbdMD to Present at ThinkEquity Conference on October 26, 2022, in New York CityNewsfile Corp • 10/25/22
cbdMD Delivers on its Promise of Operating Improvement, adds Regulatory Depth to the BoardNewsfile Corp • 08/11/22
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2022, Third Quarter ResultsNewsfile Corp • 08/08/22
cbdMD's Dr. Sibyl Swift Provides Testimony To the FDA Science Board on Proper Safety Methods for CBD ProductsNewsfile Corp • 06/29/22
cbdMD Leadership to Attend Mid-Atlantic Legislative Conference on June 1 in WVNewsfile Corp • 06/01/22
cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/17/22
CORRECTION FROM SOURCE: cbdMD, Inc. to Host Conference Call to Discuss March 31, 2022, Second Quarter ResultsNewsfile Corp • 05/06/22
cbdMD, Inc. to Host Conference Call to Discuss March 30, 2022, Second Quarter ResultsNewsfile Corp • 05/06/22